ornithine and hydroxyurea

ornithine has been researched along with hydroxyurea in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Linebaugh, BE; Rillema, JA	1
Levin, VA	1
Cannon, RO; Coles, WA; Csako, G; Gladwin, MT; Ognibene, FP; Panza, JA; Reiter, CD; Schechter, AN; Schenke, WH; Waclawiw, MA	1
Castro, O; Gladwin, MT; Harris, A; Hauser, KP; Kato, G; Little, JA; Machado, R; Maric, I; Martyr, SE; Morris, CR; Suh, JH; Taylor, J	1

Reviews

1 review(s) available for ornithine and hydroxyurea

Article	Year
Chemotherapy of primary brain tumors. Neurologic clinics, 1985, Volume: 3, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine	1985

Article

Year

Chemotherapy of primary brain tumors.

Neurologic clinics, 1985, Volume: 3, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Eflornithine; Ependymoma; Fluorouracil; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methotrexate; Mitoguazone; Mitolactol; Neoplasm Recurrence, Local; Ornithine; Prednisone; Risk; Thioguanine; Vincristine

1985

Trials

1 trial(s) available for ornithine and hydroxyurea

Article	Year
Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation, 2003, Jan-21, Volume: 107, Issue:2 Topics: Acetylcholine; Adult; Anemia, Sickle Cell; Biological Availability; Biomarkers; Black People; Blood Pressure; Creatinine; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Hydroxyurea; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Ornithine; Regional Blood Flow; Sex Factors; Vascular Cell Adhesion Molecule-1; Vasodilator Agents	2003

Article

Year

Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Circulation, 2003, Jan-21, Volume: 107, Issue:2

Topics: Acetylcholine; Adult; Anemia, Sickle Cell; Biological Availability; Biomarkers; Black People; Blood Pressure; Creatinine; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Hemodynamics; Humans; Hydroxyurea; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Ornithine; Regional Blood Flow; Sex Factors; Vascular Cell Adhesion Molecule-1; Vasodilator Agents

2003

Other Studies

2 other study(ies) available for ornithine and hydroxyurea

Article	Year
Polyamine influences on the prolactin stimulation of phosphoprotein synthesis in hydroxyurea synchronized MCF-7 human mammary epithelial cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1991, Volume: 23, Issue:9 Topics: Cell Cycle; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Hydroxyurea; Insulin; Interphase; Leucine; Ornithine; Phosphoproteins; Polyamines; Prolactin; Protein Processing, Post-Translational; Putrescine; S Phase; Spermidine; Tritium	1991
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy. European journal of haematology, 2009, Volume: 82, Issue:4 Topics: Adult; Anemia, Sickle Cell; Arginase; Arginine; beta-Globins; Citrulline; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Hemoglobin; Humans; Hydroxyurea; Male; Middle Aged; Ornithine; Phosphodiesterase Inhibitors; Piperazines; Purines; Reticulocyte Count; Sildenafil Citrate; Sulfones	2009

Article

Year

Polyamine influences on the prolactin stimulation of phosphoprotein synthesis in hydroxyurea synchronized MCF-7 human mammary epithelial cells.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1991, Volume: 23, Issue:9

Topics: Cell Cycle; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Hydroxyurea; Insulin; Interphase; Leucine; Ornithine; Phosphoproteins; Polyamines; Prolactin; Protein Processing, Post-Translational; Putrescine; S Phase; Spermidine; Tritium

1991

Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy.

European journal of haematology, 2009, Volume: 82, Issue:4

Topics: Adult; Anemia, Sickle Cell; Arginase; Arginine; beta-Globins; Citrulline; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Hemoglobin; Humans; Hydroxyurea; Male; Middle Aged; Ornithine; Phosphodiesterase Inhibitors; Piperazines; Purines; Reticulocyte Count; Sildenafil Citrate; Sulfones

2009